Overexpression of MSL1 significantly increased BIRC3, an anti-apoptotic factor, and HLA-A, a class I HLA molecule associated with antigen presentation (Figure 4E), suggesting that MSL1 modulates CD274-dependent downstream signaling, potentially affecting apoptosis and the tumor microenvironment. Here, HLA-A is linked to neoplasm.